Mr. Cody Michael Lawnichak PA-C

Recommended Articles

• What are the Topical Treatments for Psoriasis?

  The most popular treatment options for psoriasis are topical applications, like creams, lotions, and foams. These formulations are applied on the skin or scalp directly to reduce the symptoms. There are a number of options available for the treatment of psoriasis are unique to each individual who...

• How Can I Get Rid of Stretch Marks?

  Stretch marks are pink or purple streaks that appear on the skin, especially in the abdomen, thighs, upper arms, and back. This is very common in pregnant women, but may also be seen in people who gain weight, or a sudden growth during puberty. The color of the marks may gradually fade to white or...

• Making a Case for Nurse Certification

  Commonly underestimated for not being the ones carrying out a surgery as well as not being the ones spending more than 8 years in college, the role of nurses is usually overlooked or even ignored. Furthermore, cases of violence against nurses have increased tremendously during the last decade and...

• Communicating with an Alzheimer's Patient

  Many aspects have been focused on and taken into consideration when it comes to Alzheimer's research. Additional studies that support and give a better understanding, list acceptance, and encourage a positive outlook are important for those with Alzheimer's. Although the disease does indeed progress...

• Does Ultherapy Really Tighten Skin?

  What is it?Ultherapy is the only FDA approved non-surgical procedure done to lift the skin of the neck, chins and brow. It is not a surgery; it is not an injection or laser. It is an ultrasound therapy. This technique uses ultrasound to guide the clinician to the directed are of the skin where they...

• FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis

  On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...